Takeda, Mylan Drop Claims In Diabetes Drug Suit
Takeda Pharmaceutical Co. Ltd. and Mylan Inc. have agreed to dismiss claims related to one of four patents at issue in a lawsuit over Mylan's plans to develop a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article